This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueti, M. W.
Right arrow Articles by Knowles, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueti, M. W.
Right arrow Articles by Knowles, D. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2003, p. 5803-5809, Vol. 41, No. 12
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.12.5803-5809.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Expression of Equi Merozoite Antigen 2 during Development of Babesia equi in the Midgut and Salivary Gland of the Vector Tick Boophilus microplus

Massaro W. Ueti,1 Guy H. Palmer,1 Lowell S. Kappmeyer,2 Glen A. Scoles,2 and Donald P. Knowles1,2*

Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164-7040,1 Animal Disease Research Unit, USDA Agricultural Research Service, Pullman, Washington 99164-66302

Received 15 May 2003/ Returned for modification 19 August 2003/ Accepted 29 August 2003


arrow
ABSTRACT
 
Equi merozoite antigens 1 and 2 (EMA-1 and EMA-2) are Babesia equi proteins expressed on the parasite surface during infection in horses and are orthologues of proteins in Theileria spp., which are also tick-transmitted protozoal pathogens. We determined in this study whether EMA-1 and EMA-2 were expressed within the vector tick Boophilus microplus. B. equi transitions through multiple, morphologically distinct stages, including sexual stages, and these transitions culminate in the formation of infectious sporozoites in the tick salivary gland. EMA-2-positive B. equi stages in the midgut lumen and midgut epithelial cells of Boophilus microplus nymphs were identified by reactivity with monoclonal antibody 36/253.21. This monoclonal antibody also recognized B. equi in salivary glands of adult Boophilus microplus. In addition, quantification of B. equi in the mammalian host and vector tick indicated that the duration of tick feeding and parasitemia levels affected the percentage of nymphs that contained morphologically distinct B. equi organisms in the midgut. In contrast, there was no conclusive evidence that B. equi EMA-1 was expressed in either the Boophilus microplus midgut or salivary gland when monoclonal antibody 36/18.57 was used. The expression of B. equi EMA-2 in Boophilus microplus provides a marker for detecting the various development stages and facilitates the identification of novel stage-specific Babesia proteins for testing transmission-blocking immunity.


arrow
TEXT
 
Pathogens in the genus Babesia cause acute disease in animals and humans (7, 9, 11). Unlike the closely related Plasmodium spp. that cause malaria and are transmitted by mosquitoes, Babesia spp. develop within ixodid ticks (1, 27). The development of Babesia spp. within the tick begins in the midgut lumen and culminates in the formation of infectious sporozoite stages within the salivary gland acini (8, 18, 25). This development is illustrated by Babesia equi, a pathogen of horses (20, 30). Following ingestion of B. equi merozoites into the tick midgut, the parasites are stimulated to undergo gametogenesis and are fertilized to form zygotes (23, 24, 30). The zygote then adheres to and invades midgut epithelial cells and transforms into a kinete (22). Mature kinetes egress to the hemocoel and invade salivary gland acinar cells, where they undergo sequential transformations into sporonts, intermediate-form sporoblasts, and ultimately mature sporozoites, the infective stage for the mammalian host (7, 8, 9, 25). This complex development requires not only transition from a vertebrate to an invertebrate environment but also invasion of multiple distinct cell types, including erythrocytes, tick midgut epithelial cells, and tick salivary gland epithelial cells. Mediating these events is postulated to involve expression of common surface proteins throughout multiple distinct stages of the parasite or regulation of novel surface molecules by the distinct life cycle stages within the mammalian host and the vector.

In contrast to stage-specific surface molecules needed to mediate events such as attachment and invasion in the mammalian versus invertebrate host (5, 6, 16, 28), surface proteins expressed in multiple stages may mediate a function in both the mammalian host and the vector tick. Erythrocyte stages of B. equi express immunodominant surface proteins designated equi merozoite antigens (2, 13, 15). Equi merozoite antigen 1 (EMA-1; 34 kDa) and EMA-2 (30 kDa) are each encoded by paralogous single-copy genes and are expressed by intraerythrocytic parasite stages (10, 13). The high degree of similarity between EMA-1 and EMA-2 is consistent with the two proteins having a common function or closely related functions within the mammalian host. To test whether these merozoite surface molecules are expressed at critical stages within the vector tick, we examined EMA-1 and EMA-2 expression in the midgut of Boophilus microplus nymphs following acquisition feeding, and then in the salivary gland of Boophilus microplus adults at the time when infective sporozoites develop.

To maximize the levels of B. equi within Boophilus microplus, nymphal feeding was synchronized with ascending B. equi parasitemia. A splenectomized pony (H069) was inoculated with 2 ml of the Florida strain of B. equi (approximately 8 x 107 infected erythrocytes), a strain that has been shown to be transmissible by Boophilus microplus (14). To determine the number of B. equi parasites during early ascending parasitemia, real-time PCR was performed with primers derived from the single-copy gene ema-1 of B. equi (4, 13). It was predicted that the ema-1 primers (forward, 5'-GAGTCCATTGACCACGTCACC-3'; reverse, 5'-GTGCCTGACGACAGTCTTTGG-3') would amplify a fragment from nucleotide 115 to 270. The fluorogenic probe 5'-TCGACAAGCAGTCCGAGGAGCACA-3' (PE Applied Biosystems, Foster City, Calif.) was generated to anneal between bases 137 and 161 of ema-1. The TaqMan assay was carried out under the following conditions: 95°C for 10 min, 50 cycles of 95°C for 20 s and 62°C for 15 s, final extension at 72°C for 7 min, and holding at 10°C. The reactions were conducted with a PCR mixture containing 10 mM Tris (pH 8.3); 50 mM KCl; 2.0 mM MgCl2; 200 µM dATP, dCTP, dGTP, dTTP; a 0.2 µM concentration of each primer; 0.12 µM fluorogenic probe; and 1.25 U of AmpliTaq Gold (PE Applied Biosystems). All reactions were performed with the iCycler iQ real-time PCR detection system (Bio-Rad Laboratories, Hercules, Calif.). A standard curve of 103 to 107 ema-1 copies (Fig. 1) was generated by amplifying the previously reported recombinant ema-1 plasmid (14, 17). The efficiency of amplification using serial dilutions of the recombinant ema-1 plasmid ranged from 0.93 to 0.99 (12). Test samples from H069 were amplified simultaneously with the set of standards to determine the level of parasites in the peripheral blood. Real-time PCR was performed with genomic DNA isolated from 100 µl of blood by a commercially available method (Gentra Systems, Inc., Minneapolis, Minn.). The levels of B. equi in the peripheral blood, analyzed in triplicate, are presented as the mean logarithms of the numbers of B. equi parasites per microliter of blood. There were 100.96 B. equi parasites per µl of blood in pony H069 on day 6 postinoculation; this number rose to 106.2 per µl by day 15 postinoculation. In contrast to the initial detection by real-time PCR on day 6, B. equi in the peripheral blood was first detected by light-microscopic examination of Giemsa-stained smears on day 9 postinoculation (Fig. 2). During the rise in parasitemia from days 9 through 15 postinoculation, there was close agreement between the number of parasites detected by real-time PCR and the number detected by microscopic examination (Fig. 2).



View larger version (38K):
[in this window]
[in a new window]
  		FIG. 1. Real-time PCR detection of the B. equi ema-1 gene. The standard curve was generated by using a pBluescript SK(-) vector with the full-length ema-1 gene (14). The x axis indicates the log starting quantity of the template. The efficiency of amplification was 0.95.



View larger version (12K):
[in this window]
[in a new window]
  		FIG. 2. Real-time PCR detection of early ascending B. equi parasitemia. The means and standard deviations of triplicate assays for both real-time PCR and light microscopic quantification of the parasites are indicated. Boophilus microplus nymphs were applied from days 3 through 7 postinoculation and were harvested from days 9 through 15 postinoculation.

To generate Boophilus microplus nymphs, larvae were allowed to feed on a normal calf for 5 days. Engorged larvae were harvested and induced to molt to the nymphal stage within 48 h at 26°C, with 93% relative humidity and a 12-h photoperiod. Unfed nymphs were applied under individual cloth patches on H069 on days 3, 4, 5, 6, and 7 postinoculation and allowed to feed for a minimum of 2 days and a maximum of 8 days during ascending B. equi parasitemia. Nymphs were harvested at days 9 through 15 after B. equi inoculation during parasitemia levels between 102.8 to 106.2 per µl of blood (Fig. 2). Negative control Boophilus microplus nymphs were obtained by using the same colony and fed identically on an uninfected pony.

Following nymphal acquisition feeding, we tested whether EMA-1 and EMA-2 were expressed during the development of B. equi within Boophilus microplus nymphs. Partially fed nymphs harvested on days 9 through 15 postinoculation were promptly fixed in 10% formaldehyde for 8 to 18 h and embedded in paraffin. Following deparaffinization in Clear-Rite (Richard-Allan Scientific, Kalamazoo, Mich.), 4-µm sections were treated with target retrieval solution (DAKO Corp., Carpinteria, Calif.) and steam for 20 min and then cooled at room temperature prior to immunostaining (19, 21, 26). The tick sections were blocked with 5% normal goat serum in 0.01 M phosphate-buffered saline containing NaN3. B. equi-specific monoclonal antibodies (MAbs) 36/18.57 (5 µg/ml) against EMA-1, 36/253.21 (0.1 µg/ml) against EMA-2, and 36/133.97 (5 µg/ml) against EMA-1 and EMA-2 (Fig. 3) were applied to tick sections, and the sections were incubated at room temperature for 25 min. The hybridomas secreting these MAbs were generated from BALB/c mice immunized with viable B. equi erythrocyte stages as previously described (15). Goat anti-mouse immunoglobulin G (Signet Pathology Systems, Inc., Dedham, Mass.) was applied following the primary antibodies, and the tick sections were incubated at room temperature for 25 min. The tick sections were treated with 3% hydrogen peroxide in distilled water and incubated at room temperature for 6 min. Following the hydrogen peroxide treatment, streptavidin-horseradish peroxidase was applied to the sections, and the sections were incubated at room temperature for 25 min. The substrate was 3-amino-9-ethylcarbazole containing hydrogen peroxide (DAKO Corp.), and tick sections were incubated at room temperature for 7 min. All sections were counterstained with Mayer's hematoxylin and mounted on coverslips with an aqueous mounting medium.



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 3. Specificity of MAbs 36/133.97, 36/18.57, and 36/253.21. Immunoaffinity-purified native EMA-1 and EMA-2 from B. equi erythrocyte stages were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and incubated with individual MAbs. The immunoblotted proteins were probed with MAb 36/133.97 against an epitope common to EMA-1 and EMA-2, MAb 36/18.57 against EMA-1, MAb 36/253.21 against EMA-2, and the isotype-matched control MAb 18.185 against C. parvum. The 43- and 29-kDa molecular size standards are indicated on the left.

B. equi-specific MAbs 36/253.21 (anti-EMA-2) and 36/133.97 (anti-EMA-1 and -2) recognized B. equi forms 1.5 to 5 µm in diameter in the midgut of exposed nymphs. No reactivity was observed in sections of uninfected nymphs probed with either antibody or in sections of infected nymphs probed with isotype-matched control MAb 18.185 against Cryptosporidium parvum. The anti-EMA-1 MAb 36/18.57 showed no reactivity in sections of infected nymphs or in the B. equi erythrocyte stages concentrated in 1% agarose, fixed in 10% formaldehyde, and embedded in paraffin. The percentage of fed nymphs that contained EMA-2-positive B. equi was positively associated with the parasitemia level (Table 1). In addition to the percentage of nymphs containing B. equi, the morphology and location of the EMA-2-positive organisms within the midgut also varied in association with the parasitemia level and duration of feeding. Nymphs fed on pony H069 with parasite levels in the peripheral blood below 105.7 per µl of blood contained B. equi forms 1.5 to 2.5 µm in diameter in the midgut lumen only (Fig. 4). These forms were morphologically indistinguishable from the B. equi erythrocyte stages. In contrast, nymphs fed when parasitemia exceeded 105.7 per µl of blood contained B. equi forms of up to 5 µm in diameter in both the midgut lumen and midgut epithelial cells (Fig. 5), indicating the development of morphologically distinct stages. In addition to the influence of parasitemia on B. equi stages in the midgut, the duration of tick feeding also appeared to affect the development of B. equi in the midgut. Nymphs fed for 2 to 3 days at parasitemia levels below 103.9 per µl of blood showed no reactivity of antibodies in the midgut. The percentage of nymphs which had detectable B. equi within the midgut was 26.4% when nymphs were fed for 4 to 6 days at parasite levels below 105.7 per µl of blood. In contrast, 60% of nymphs fed for 6 days at parasite levels exceeding 105.7 per µl of blood contained B. equi. The highest percentage of nymphs containing B. equi in the midgut (66 to 100%) was observed when nymphs were allowed to feed for 7 or 8 days at parasitemia levels exceeding 105.7 per µl of blood (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Association between B. equi parasitemia level and presence of EMA-2-positive B. equi in the midgut



View larger version (85K):
[in this window]
[in a new window]
  		FIG. 4. Expression of EMA-2 by B. equi within the midgut lumen of Boophilus microplus nymphs fed during parasitemia levels below 105.7 per µl of blood. (a) Semithin section of an infected nymph probed with MAb 36/253.21; (b) sequential section of an infected nymph probed with isotype-matched control MAb 18.185; (c) section of an uninfected nymph probed with MAb 36/253.21. L, midgut lumen; Ep, midgut epithelial cells. Arrows indicate B. equi in the midgut lumen.



View larger version (79K):
[in this window]
[in a new window]
  		FIG. 5. Expression of EMA-2 by B. equi within the midguts of Boophilus microplus nymphs fed during parasitemia at levels exceeding 105.7 parasites per µl of blood. (a) Semithin section of an infected nymph probed with MAb 36/253.21; (b) sequential section of an infected nymph probed with isotype-matched control MAb 18.185; (c) section of an uninfected nymph probed with MAb 36/253.21. L, midgut lumen; Ep, midgut epithelial cells. Arrows indicate B. equi in the midgut.

Having identified the expression of EMA-2 by B. equi within the midgut of Boophilus microplus nymphs, we examined whether EMA-1 and EMA-2 were expressed by B. equi during development in the salivary glands of B. microplus adults. The engorged nymphs, infected by feeding on H069 for 9 to 11 days during ascending parasitemia, were harvested and induced to molt to the adult stage within 48 to 72 h by incubation at 26°C, 93% relative humidity, and a 12-h photoperiod. The adults were allowed to feed on a normal calf for 48 h to stimulate the development of B. equi in the salivary gland acinar cells (29). To determine if Boophilus microplus ticks exposed to B. equi as nymphs were infected, adult ticks were dissected and the salivary glands were isolated. Duplex nested PCR was carried out with genomic DNA from 10 individual salivary gland pairs extracted by a commercially available method (Gentra Systems, Inc.). The PCR mixtures contained two sets of primers, one to amplify the Boophilus microplus {alpha}-tubulin gene and the other to amplify B. equi ema-1 (3, 10). It was predicted that Boophilus microplus {alpha}-tubulin primers (forward, 5'-CGTGCCGTATTTGTTGATC-3'; reverse, 5'-AGATTAGCTGCTCCGGGTG-3') would amplify a fragment of 91 bp. It was predicted that the ema-1 external primers (forward, 5'-CCGAGGAGGAGAAACCCA-3'; reverse, 5'-CGCCATAGACGGAGAAGCC-3') would amplify a fragment from nucleotide 165 to 778. The PCR was carried out under the following conditions: 94°C for 5 min; 30 cycles of 95°C for 30 s, 62°C for 30 s, and 72°C for 20 s; final extension at 72°C for 7 min; and holding at 4°C. The reaction was conducted in 25 µl containing 5 µl of extracted genomic DNA, a 1.6 µM concentration of each primer set, and 12.5 µl of PCR Master (Roche Diagnostics Corp., Nutley, N.J.). It was predicted that the ema-1 internal primers (forward, 5'-AAGGACAACAAGCCATACGT-3'; reverse, 5'-TTGCCTGGAGCCTTGAAG-3') would amplify a fragment of 226 bp (nucleotides 274 to 500). The duplex nested PCR was carried out under the following conditions: 94°C for 5 min; 25 cycles of 94°C for 15 s, 62°C for 20 s, and 72°C for 15 s; final extension at 72°C for 7 min; and holding at 4°C. The reaction was conducted in 25 µl containing 1 µl from the first reaction, a 2 µM concentration of each primer set (ema-1 internal primers and Boophilus microplus {alpha}-tubulin primers), and 12.5 µl of PCR Master. The duplex nested PCR products were analyzed following 2% agarose gel electrophoresis. All salivary glands from adult ticks revealed the expected band for {alpha}-tubulin amplification and 3 of 10 contained B. equi amplicons (Fig. 6).



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 6. Identification of B. equi-infected salivary glands from individual Boophilus microplus adults exposed as nymphs. uB. micro, salivary glands uninfected Boophilus microplus; H069, infected pony; B. micro 1 to 10, salivary glands from individual Boophilus microplus ticks. Molecular size markers are indicated at the right.

Having confirmed the infection of adult ticks by PCR, we examined whether EMA-1 and EMA-2 were expressed by B. equi during development in the salivary glands. Adult ticks that had been fed to stimulate B. equi development in the salivary gland were fixed in 10% formaldehyde and embedded in paraffin. Semithin sections of Boophilus microplus adults exposed to B. equi as nymphs were probed with antibodies 36/18.57, 36/253.21, and 36/133.97. B. equi-specific MAbs 36/253.21 (anti-EMA-2) and 36/133.97 (anti-EMA-1 and -2) recognized B. equi in the salivary gland, but neither 36/18.57 (anti-EMA-1) nor the isotype-matched control MAb 18.185 (anti-C. parvum) bound B. equi in sequential sections of infected salivary glands (Fig. 7). None of the antibodies bound the salivary glands of uninfected Boophilus microplus adults.



View larger version (153K):
[in this window]
[in a new window]
  		FIG. 7. Expression of EMA-2 by B. equi within the salivary glands of Boophilus microplus adults. (a) Semithin section of an infected Boophilus microplus adult probed with MAb 36/253.21; (b) sequential semithin section of an infected Boophilus microplus adult probed with isotype-matched control MAb 18.185; (c) sequential semithin section of an infected Boophilus microplus adult probed with MAb 36/133.97; (d) semithin section of an uninfected Boophilus microplus adult probed with MAb 36/253.21. Sg, salivary gland.

Expression of surface proteins throughout complex multiple stages of Babesia suggests that these conserved proteins play a fundamental role in the life cycle of the parasite within the vector tick and the mammalian host. We have conclusive evidence that the EMA-2 protein is expressed during B. equi stages within the midgut of nymphs and within the salivary glands of adult ticks, as well as in the erythrocyte stages in the mammalian host (13). Previous data demonstrated that EMA-2 is an orthologue of proteins in Theileria spp., closely related tick-transmitted protozoans (10, 13). The presence of EMA-2 expressed by B. equi at multiple stages within the mammalian host and the vector tick and the conservation in Babesia and Theileria parasites are consistent with a required function in the mammalian host, in the vector tick, or in both. In contrast to conclusive data for EMA-2, whether EMA-1 is expressed in the vector tick is unclear. The reactivity of MAb 36/133.97 with B. equi at the midgut and salivary gland stages may result from binding only to EMA-2 or may reflect coexpression of EMA-1 and EMA-2. MAb 36/18.57, with specificity solely for EMA-1, failed to bind formalin-fixed parasites even when intraerythrocytic stages, previously shown to express EMA-1 by other techniques, were examined. Development of a larger repertoire of EMA-1-specific MAbs that function in immunohistochemistry may be needed to conclusively determine whether EMA-1 is expressed by B. equi at different stages in ticks.

The development of morphologically distinct EMA-2-positive parasites in the nymphal midgut had a positive association with the parasitemia level of the mammalian host and the duration of tick feeding. Combined with establishing that tick feeding for at least 6 days at parasitemia levels greater than 105.7 B. equi parasites per µl of blood enriches the number of B. equi stages in the midguts of nymphs, the use of EMA-2 as a parasite marker will also facilitate the identification of stage-specific Babesia proteins in the vector tick. Stage-specific Babesia molecules expressed in the midgut of the vector are potential targets for transmission-blocking immunity (5, 6, 16, 28). The ultimate goal of transmission-blocking immunity is to prevent infection or clinical disease by reducing tick infectivity for susceptible mammalian hosts.


arrow
ACKNOWLEDGMENTS
 
We thank Ralph Horn for his excellent technical assistance. Also, we thank Terry F. McElwain and Travis C. McGuire of the Department of Veterinary Microbiology and Pathology, Washington State University, for their critical review of the manuscript.

This work was supported by U.S. Department of Agriculture-ARS-ADRU project number 5348-32000-020D and by CAPEs Foundation through the Brazilian Government (BEX069/98-8).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040. Phone: (509) 335-6022. Fax: (509) 335-8328. E-mail: dknowles{at}vetmed.wsu.edu. Back


arrow
REFERENCES
 
    1
  1. Armstrong, P. M., P. Katavolos, D. A. Caporale, R. P. Smith, A. Spielman, and S. R. Telford. 1998. Diversity of Babesia infecting deer ticks (Ixodes dammini). Am. J. Trop. Med. Hyg. 58:739-742.[Abstract]
    2. 2
  2. Bose, R., and B. Hentrich. 1994. Identification of antigens diagnostic for European isolates of Babesia equi by two-dimensional electrophoresis and Western blotting. Parasitol. Res. 80:182-185.[CrossRef][Medline]
    3. 3
  3. Crampton, A. L., C. Miller, G. D. Baxter, and S. C. Barker. 1998. Expressed sequenced tags and new genes from the cattle tick, Boophilus microplus. Exp. Appl. Acarol. 22:177-186.[Medline]
    4. 4
  4. Cunha, C. W., L. S. Kappmeyer, T. C. McGuire, O. A. Dellagostin, and D. P. Knowles. 2002. Conformational dependence and conservation of an immunodominant epitope within the Babesia equi erythrocyte-stage surface protein equi merozoite antigen-1. Clin. Diagn. Lab. Immunol. 9:1301-1306.[Abstract/Free Full Text]
    5. 5
  5. Duffy, P. E., and D. C. Kaslow. 1997. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect. Immun. 65:1109-1113.[Abstract]
    6. 6
  6. Eksi, S., and K. C. Williamson. 2002. Male-specific expression of the paralog of malaria transmission-blocking target antigen Pfs230, PfB0400w. Mol. Biochem. Parasitol. 122:127-130.[CrossRef][Medline]
    7. 7
  7. Friedhoff, K. T. 1988. Transmission of Babesia, p. 23-52. In M. Ristic (ed.), Babesiosis of domestic animals and man. CRC Press, Boca Raton, Fla.
    8. 8
  8. Guimaraes, A. M., J. D. Lima, and M. F. B. Ribeiro. 1998. Sporogony and experimental transmission of Babesia equi by Boophilus microplus. Parasitol. Res. 84:323-327.[CrossRef][Medline]
    9. 9
  9. Homer, M. J., I. Aguilar-Delfin, S. R. Telford, P. J. Krause, and D. H. Persing. 2000. Babesiosis. Clin. Microbiol. Rev. 13:451-469.[Abstract/Free Full Text]
    10. 10
  10. Kappmeyer, L. S., L. E. Perryman, and D. P. Knowles. 1993. A Babesia equi gene encodes a surface protein with homology to Theileria species. Mol. Biochem. Parasitol. 62:121-124.[CrossRef][Medline]
    11. 11
  11. Kjemtrup, A. M., and P. A. Conrad. 2000. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30:1323-1337.[CrossRef][Medline]
    12. 12
  12. Klein, D., P. Janda, R. Steinborn, M. Muller, B. Salmons, and W. H. Gunzburg. 1999. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis 20:291-299.[CrossRef][Medline]
    13. 13
  13. Knowles, D. P., L. S. Kappmeyer, and L. E. Perryman. 1997. Genetic and biochemical analysis of erythrocyte-stage surface antigens belonging to a family of highly conserved proteins of Babesia equi and Theileria species. Mol. Biochem. Parasitol. 90:69-79.[CrossRef][Medline]
    14. 14
  14. Knowles, D. P., L. S. Kappmeyer, D. Stiller, S. G. Hennager, and L. E. Perryman. 1992. Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi. J. Clin. Microbiol. 30:3122-3126.[Abstract/Free Full Text]
    15. 15
  15. Knowles, D. P., L. E. Perryman, W. L. Goff, C. D. Miller, R. D. Harrington, and J. R. Gorham. 1991. A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites. Infect. Immun. 59:2412-2417.[Abstract/Free Full Text]
    16. 16
  16. Langer, R. C., F. Li, and J. M. Vinetz. 2002. Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission. Infect. Immun. 70:102-106.[Abstract/Free Full Text]
    17. 17
  17. Lohr, C. V., F. R. Rurangirwa, T. F. McElwain, D. Stiller, and G. H. Palmer. 2002. Specific expression of Anaplasma marginale major surface protein 2 salivary gland variants occurs in the midgut and is an early event during tick transmission. Infect. Immun. 70:114-120.[Abstract/Free Full Text]
    18. 18
  18. Mehlhorn, H., and E. Schein. 1998. Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998. Parasitol. Res. 84:467-475.[CrossRef][Medline]
    19. 19
  19. Miller, J. M., A. L. Jenny, W. D. Taylor, R. E. Race, D. R. Ernst, J. B. Katz, and R. Rubenstein. 1994. Detection of prion protein in formalin-fixed brain by hydrated autoclaving immunohistochemistry for the diagnosis of scrapie in sheep. J. Vet. Diagn. Investig. 6:366-368.[Free Full Text]
    20. 20
  20. Moltmann, U. G., H. Mehlhorn, E. Schein, W. P. Voigt, and K. T. Friedhoff. 1983. Ultrastructural study on the development of Babesia equi (Coccidia: Piroplasmia) in the salivary glands of its vector ticks. J. Protozool. 30:218-225.[Medline]
    21. 21
  21. O'Rourke, K. I., T. V. Baszler, J. M. Miller, T. R. Spraker, I. Sadler-Riggleman, and D. P. Knowles. 1998. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein. J. Clin. Microbiol. 36:1750-1755.[Abstract/Free Full Text]
    22. 22
  22. Rudzinska, M. A., S. Lewengrub, A. Spielman, and J. Piesman. 1983. Invasion of Babesia microti into epithelial cells of the tick gut. J. Protozool. 30:338-346.[Medline]
    23. 23
  23. Rudzinska, M. A., A. Spielman, S. Lewengrub, W. Trager, and J. Piesman. 1983. Sexuality in piroplasms as revealed by electron microscopy in Babesia microti. Proc. Natl. Acad. Sci. USA 80:2966-2970.[Abstract/Free Full Text]
    24. 24
  24. Rudzinska, M. A., A. Spielman, R. F. Riek, S. J. Lewengrub, and J. Piesman. 1979. Intraerythrocytic 'gametocytes' of Babesia microti and their maturation in ticks. Can. J. Zool. 57:424-434.[Medline]
    25. 25
  25. Schein, E. 1988. Equine babesiosis, p. 197-208. In M. Ristic (ed.), Babesiosis of domestic animals and man. CRC Press, Boca Raton, Fla.
    26. 26
  26. Shi, S. R., R. J. Cote, and C. R. Taylor. 1997. Antigen retrieval immunohistochemistry: past, present, and future. J. Histochem. Cytochem. 45:327-343.[Abstract/Free Full Text]
    27. 27
  27. Stiller, D., W. L. Goff, L. W. Johnson, and D. P. Knowles. 2002. Dermacentor variabilis and Boophilus microplus (Acari: Ixodidae): experimental vectors of Babesia equi to equids. J. Med. Entomol. 39:667-670.[Medline]
    28. 28
  28. Williamson, K. C., H. Fujioka, M. Aikawa, and D. C. Kaslow. 1996. Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate. Mol. Biochem. Parasitol. 78:161-169.[CrossRef][Medline]
    29. 29
  29. Zapf, F., and E. Schein. 1994. New findings in the development of Babesia (Theileria) equi (Laveran, 1901) in the salivary glands of the vector ticks, Hyalomma species. Parasitol. Res. 80:543-548.[CrossRef][Medline]
    30. 30
  30. Zapf, F., and E. Schein. 1994. The development of Babesia (Theileria) equi (Laveran, 1901) in the gut and the hemolymph of the vector ticks, Hyalomma species. Parasitol. Res. 80:297-302.[CrossRef][Medline]

Journal of Clinical Microbiology, December 2003, p. 5803-5809, Vol. 41, No. 12
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.12.5803-5809.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ueti, M. W., Palmer, G. H., Scoles, G. A., Kappmeyer, L. S., Knowles, D. P. (2008). Persistently Infected Horses Are Reservoirs for Intrastadial Tick-Borne Transmission of the Apicomplexan Parasite Babesia equi. Infect. Immun. 76: 3525-3529 [Abstract] [Full Text]  
  • Ueti, M. W., Reagan, J. O. Jr., Knowles, D. P. Jr., Scoles, G. A., Shkap, V., Palmer, G. H. (2007). Identification of Midgut and Salivary Glands as Specific and Distinct Barriers to Efficient Tick-Borne Transmission of Anaplasma marginale. Infect. Immun. 75: 2959-2964 [Abstract] [Full Text]  
  • IKADAI, H., SASAKI, M., ISHIDA, H., MATSUU, A., IGARASHI, I., FUJISAKI, K., OYAMADA, T. (2007). MOLECULAR EVIDENCE OF BABESIA EQUI TRANSMISSION IN HAEMAPHYSALIS LONGICORNIS. Am J Trop Med Hyg 76: 694-697 [Abstract] [Full Text]  
  • Ueti, M. W., Palmer, G. H., Kappmeyer, L. S., Statdfield, M., Scoles, G. A., Knowles, D. P. (2005). Ability of the Vector Tick Boophilus microplus To Acquire and Transmit Babesia equi following Feeding on Chronically Infected Horses with Low-Level Parasitemia. J. Clin. Microbiol. 43: 3755-3759 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueti, M. W.
Right arrow Articles by Knowles, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueti, M. W.
Right arrow Articles by Knowles, D. P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»